Overview
- 13 inspections across 13 sites are on record.
- 30 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-16.
At a glance
Inspections
13
Sites
13
Observations
30
Career since
Nov 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Xttrium Laboratories, Inc. | 16 Jun 2026 | Human Drugs | On file |
| Topical Pharmaceuticals, Inc. | 7 May 2026 | Human Drugs | View 483 → |
| Fresenius Kabi USA LLC | 18 Feb 2026 | Human Drugs | On file |
| Creative Werks LLC | 22 Jan 2026 | Human Drugs | View 483 → |
| Frontida Biopharm, LLC | 24 Oct 2025 | Human Drugs | View 483 → |
Sites inspected
Xttrium Laboratories, Inc.Mount Prospect, United States1 insp.
Topical Pharmaceuticals, Inc.Addison, United States1 insp.
Fresenius Kabi USA LLCMelrose Park, United States1 insp.
Creative Werks LLCElk Grove Village, United States1 insp.
Frontida Biopharm, LLCAurora, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
JeanClaude Garay5 shared
Gabriel Bermudez-Picart2 shared
Tyler M Peterson2 shared
Michele L Glendenning2 shared
Michael A Charles2 shared
Chikitsa S Patel1 shared
Scott D Mcgrew1 shared
Joseph A Piechocki1 shared
Joohi Castelvetere1 shared
Andrew J Barrowcliff1 shared
Full investigator report
Get the verbatim findings behind Angela C Welker's 30 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site